Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M44,243Revenue (TTM) $M101,600Net Margin (%)2.7Altman Z-Score3.2
Enterprise Value $M58,055EPS (TTM) $4.2Operating Margin %4.8Piotroski F-Score8
P/E(ttm)17.0Beneish M-Score-2.8Pre-tax Margin (%)4.1Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %22.5Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.55-y EBITDA Growth Rate %17.1Current Ratio0.7Lower Leverage y-yN
Price/Free Cash Flow9.2y-y EBITDA Growth Rate %21.0ROA % (ttm)5.3Higher Current Ratio y-yY
Dividend Yield %--PEG1.0ROE % (ttm)17.2Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M617ROIC % (ttm)10.6Gross Margin Increase y-yY

Gurus Latest Trades with ESRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ESRXArnold Van Den Berg 2016-12-31 Sold Out -1.1%$65.09 - $77.14
($71.67)
$ 71.750%Sold Out0
ESRXKen Fisher 2016-12-31 Add$65.09 - $77.14
($71.67)
$ 71.750%Add 1.66%353,137
ESRXDavid Dreman 2016-09-30 Reduce-0.69%$69.25 - $79.68
($74.78)
$ 71.75-4%Reduce -54.60%12,314
ESRXBarrow, Hanley, Mewhinney & Strauss 2016-09-30 Add0.3%$69.25 - $79.68
($74.78)
$ 71.75-4%Add 18.85%17,407,316
ESRXHOTCHKIS & WILEY 2016-09-30 Sold Out -0.25%$69.25 - $79.68
($74.78)
$ 71.75-4%Sold Out0
ESRXWallace Weitz 2016-09-30 Reduce-0.13%$69.25 - $79.68
($74.78)
$ 71.75-4%Reduce -4.40%1,000,693
ESRXChris Davis 2016-09-30 Reduce-0.11%$69.25 - $79.68
($74.78)
$ 71.75-4%Reduce -6.39%4,638,868
ESRXRobert Olstein 2016-09-30 Add0.1%$69.25 - $79.68
($74.78)
$ 71.75-4%Add 8.31%142,000
ESRXJoel Greenblatt 2016-09-30 Reduce-0.08%$69.25 - $79.68
($74.78)
$ 71.75-4%Reduce -9.47%871,757
ESRXMario Gabelli 2016-09-30 Reduce-0.05%$69.25 - $79.68
($74.78)
$ 71.75-4%Reduce -95.01%4,880
ESRXDodge & Cox 2016-09-30 Reduce-0.02%$69.25 - $79.68
($74.78)
$ 71.75-4%Reduce -1.30%21,410,369
ESRXArnold Van Den Berg 2016-09-30 Reduce-0.02%$69.25 - $79.68
($74.78)
$ 71.75-4%Reduce -1.50%96,155
ESRXCharles Brandes 2016-09-30 Add$69.25 - $79.68
($74.78)
$ 71.75-4%Add 0.13%2,129,437
ESRXKen Fisher 2016-09-30 Reduce$69.25 - $79.68
($74.78)
$ 71.75-4%Reduce -1.34%347,357
ESRXRichard Pzena 2016-09-30 Buy $69.25 - $79.68
($74.78)
$ 71.75-4%New holding3,507
ESRXArnold Van Den Berg 2016-06-30 Buy 1.24%$67.24 - $76.95
($73.45)
$ 71.75-2%New holding97,615
ESRXBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Add0.56%$67.24 - $76.95
($73.45)
$ 71.75-2%Add 49.88%14,646,371
ESRXDavid Dreman 2016-06-30 Add0.54%$67.24 - $76.95
($73.45)
$ 71.75-2%Add 74.94%27,122
ESRXHOTCHKIS & WILEY 2016-06-30 Reduce-0.23%$67.24 - $76.95
($73.45)
$ 71.75-2%Reduce -50.14%775,261
ESRXJoel Greenblatt 2016-06-30 Reduce-0.15%$67.24 - $76.95
($73.45)
$ 71.75-2%Reduce -16.87%962,979
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ESRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ESRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Neville EverettSr. VP, Sup. Chain & Specialty 2017-01-03Sell1,123$69.413.37view
Miller Steven BSr. VP & Chief Med. Officer 2016-11-09Sell21,798$75.02-4.36view
Anderson Phyllis S.Sr. VP & Ch. Marketing Officer 2016-11-09Sell642$74.74-4view
MYERS WOODROW A JRDirector 2016-09-14Sell12,036$70.41.92view
McGinnis Christopher AVP, Controller & Ch. Acct. Off 2016-09-12Sell1,785$70.771.38view
Neville EverettSenior VP, Supply Chain 2016-05-10Sell800$74.11-3.18view
MAC MAHON THOMAS PDirector 2016-04-29Sell5,482$73.93-2.95view
McGinnis Christopher AVP, Controller & Ch. Acct. Off 2016-03-10Sell579$68.564.65view
Anderson Phyllis S.Sr. VP & Ch. Marketing Officer 2016-03-07Sell614$71.140.86view
Houston ChristineSenior VP, Operations 2016-03-01Sell8,721$71.550.28view

Quarterly/Annual Reports about ESRX:

News about ESRX:

Articles On GuruFocus.com
Steven Romick Spots Next Area of Interest, Health Care Jan 13 2017 
2 Top Health Care Dividend Stocks Jan 12 2017 
Gilead Sciences Must Answer to Investors After a Disappointing 2016 Jan 05 2017 
Mean Reversion and the Bell Curve Jan 03 2017 
Express Scripts to Include Harvoni in Hepatitis Cure Value Program Dec 13 2016 
Analysis of AmerisourceBergen's Dividend Increase Nov 17 2016 
Weitz Funds Comments on Express Scripts Nov 11 2016 
Weitz Balanced Fund 3rd Quarter Commentary Nov 11 2016 
Wally Weitz Comments on Express Scripts Nov 08 2016 
Wally Weitz's Partners Value Fund 3rd Quarter Commentary Nov 08 2016 

More From Other Websites
Express Scripts Holding Company Announces Fourth Quarter and Full Year 2016 Earnings Conference Call Jan 18 2017
Express Scripts Holding Co. breached its 50 day moving average in a Bullish Manner : ESRX-US :... Jan 11 2017
Mylan CEO: Trump a very business-minded, solution-oriente... Jan 10 2017
Mylan CEO: EpiPen started a much-needed conversation in h... Jan 10 2017
Express Scripts CEO: Many drug list prices are still too ... Jan 10 2017
Cheating Death Can Cost $200,000 as Cancer Tops Pharma Sales Jan 06 2017
Cheating Death Can Cost $200,000 as Cancer Leads Sales Jan 06 2017
Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference Jan 04 2017
Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference Jan 04 2017
Bob Doll's top 5 stocks for 2017 Dec 21 2016
Why Healthcare and Trade Stocks Tempered Moat Index Upside Dec 20 2016
Year In Review 2016: Leadership changes at Express Scripts, Centene expansion headline health care Dec 19 2016
Factors behind Horizon Pharma’s Volatility in December Dec 19 2016
Mylan launching generic EpiPen Dec 16 2016
Express Scripts board adds 65 million shares to buyback program Dec 16 2016
EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Other Events Dec 16 2016
Express Scripts Not Worried About A Trump Presidency Dec 16 2016
The Zacks Analyst Blog Highlights: FedEx, Express Scripts, Mondelez, Lockheed Martin and Medtronic Dec 16 2016
Top Research Reports for FedEx, Mondolez & Express Scripts Dec 15 2016
Selloff In Express Scripts Surprising To Barclays Dec 15 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)